TBPH Theravance Biopharma, Inc.
$17.03▲ +0.00%
Healthcare
Other
Volume 10.02M
Avg Volume (10D) 1.90M
Key Metrics & Fundamentals
Market Cap
$884.18M
P/E Ratio
16.4
Div Yield
–%
52W Range
13.08 - 21.03
% vs 50 MA
0.37%
% vs 200 MA
-0.79%
RSI-14
53.2
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.48
Free Cash Flow
-$6.97M
Gross Rev
$20.73M
Gross Profit
$20.73M
EBITDA
$5.84M
COGS
–
Operating Exp
$18.89M
Operating Income
$1.84M
EBIT
$1.84M
Pretax Income
-$4.79M
Net Income
-$5.90M
EPS (Diluted)
-0.11
Price & Volume History
Loading chart…
Recent News
No recent news found for TBPH.
Financial Overview - Income Statement
Quarterly
Jun 2026
See TBPH's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.